Ledger.Open graph →
SEC Form D · Amendment · filed May 22, 2019

Beacon Biomedical Inc

Offering
$3.6M
Sold
$367K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHOENIX, AZ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Donald F. Weber · PHOENIX, AZExec · DirectorDirk F. Beth · PHOENIX, AZExec · DirectorJames Kattan · George Town, Grand Cayman, Cayman IslandsExec · DirectorDouglas A. Bosnik · Fairlawn, OHExec · DirectorThe Rev. Dr. William B. Lupfer · New York, NYExec · DirectorMoshe Koyfman · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗